Aging
Navigate
Submit an Article
Research Paper|Volume 16, Issue 2|pp. 1218–1236
Development and validation of a combined cuproptosis and immunogenic cell death prognostic model for diffuse large B-cell lymphoma
Back to articleFigure 2(2 of 8)
100%
Figure 2
Figure 2.Developing a predictive risk model using the CRIRLs in DLBCL. (A) Distribution of the patients’ normalized risk score. (B) Analysis of clinical prognosis in low-risk and high-risk groups of DLBCL samples. (C) Patients’ survival status along with their risk score. (D) t-SNE analysis. (E) PCA analysis. (F) The heatmap diagram of the expression of 4 prognostic CRIRLs.
Figure 2 — Development and validation of a combined cuproptosis and immunogenic cell death prognostic model for diffuse large B-cell lymphoma | Aging